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Abstract
The hepatitis E virus (HEV) is a small RNA virus and the cause of acute viral hepatitis E. The open reading frame 3 protein
(pORF3) of HEV appears to be a pleiotropic regulatory protein that helps in the establishment, propagation and progression
of viral infection. However, the global cellular effects of this protein remain to be explored. In the absence of traditional in
vitro viral infection systems or efficient replicon systems, we made an adenovirus based ORF3 protein expression system to
study its effects on host cell gene expression. We infected Huh7 hepatoma cells with recombinant adenoviruses expressing
pORF3 and performed microarray-based gene expression analyses. Several genes down regulated in pORF3-expressing cells
were found to be under regulation of the liver-enriched hepatocyte nuclear factor 4 (HNF4), which regulates hepatocyte-
specific gene expression. While HNF4 localizes to the nucleus, its phosphorylation results in impaired nuclear localization of
HNF4. Here we report that pORF3 increases HNF4 phosphorylation through the ERK and Akt kinases, which results in
impaired nuclear translocation of HNF4 and subsequently the down modulation of HNF4-responsive genes in pORF3-
expressing cells. We propose that modulation of several hepatocyte specific genes by pORF3 will create an environment
favorable for viral replication and pathogenesis.
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Introduction
Hepatitis E virus (HEV) is the causative agent for hepatitis E, a
waterborne disease that occurs sporadically and as focused
outbreaks [1,2]. It is endemic in large parts of Asia, Africa and
Latin America from where large and small outbreaks and sporadic
disease have also been reported [3]; about 2 billion people are
estimated to live in areas where HEV infection is endemic [4].
While the infection is generally acute and self-limiting, up to 30%
mortality has been reported following HEV infection during
pregnancy [5]. Recently classified as a Hepevirus belonging to the
family Hepeviridae, HEV is a non-enveloped virus with an ,7.2 kb
capped and polyadenylated positive sense RNA genome, which
contains three open reading frames (ORFs). The orf1 encodes the
viral nonstructural polyprotein, orf2 codes for the viral capsid
protein, and orf3 encodes a small protein that is proposed to
optimize the host cell environment for viral replication.
The orf3 of HEV encodes a protein of 123 amino acids; a recent
report proposed pORF3 to be translated from a bicistronic
subgenomic RNA and to be 9 aa shorter [6]. Both the ORF3
proteins (123aa and 114aa) behave similarly in terms of their
localization and functional effects in subgenomic expression systems
[7]. The ORF3 protein is phosphorylated at a single serine residue
by the cellular mitogen-activated protein kinase [8]. It contains two
hydrophobic domains in its N-terminal half and two proline-rich
regions in its C-terminal half, one of which contains the
phosphorylated serine residue [8]. The other proline-rich region
contains a PXXPXXP (where X is any other residue) motif that was
shown to bind several proteins with src-homology 3 domains [9]. It
was subsequently demonstrated that pORF3 activated the extra-
cellularly regulated kinase, a member of the mitogen-activated
protein kinase family of proteins, by binding and inhibiting its
cognate phosphatase [10]. The ORF3 protein also attenuates the
mitochondrial death pathway [11] and upregulates the expression
of glycolytic pathway genes through the stabilization of hypoxia-
inducible factor 1 [12]. We recently showed that pORF3 delays the
movement of activated epidermal growth factor (EGF) receptors
(EGFRs) and hepatocytegrowth factor(HGF) receptors (c-Met)into
the degradative compartment, which is likely to result in extended
growth factor signaling from intracellular sites [7,13]. This effect on
EGFR movement was also found to retard the nuclear transport of
phosphorylated signal transducer and activator of transcription 3
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22412(pSTAT3), which attenuates the acute-phase response, a major
inflammatory pathway in the liver [7].
All previous in vitro expression studies have shown pORF3 to
regulate cellular processes and to have three broad roles. The first is
the promotion of cell survival through activation of the ERK/
MAPK signaling pathway, attenuation of the intrinsic death
pathway, regulation of energy homeostasis, and increased growth
factor signaling [7,10,11,12]. Secondly, it attenuates host immune
responses through reduced expression of acute-phase proteins and
increased secretion of the immunosuppressive a1-microglobulin
protein [7,14]. Finally, recent reports have also suggested that
pORF3 is required for virion morphogenesis and egress from
infected cells [15]. Thus, pORF3 appears to be a regulatory protein
required for the establishment, propagation, and progression of
HEVinfection. Indeed, itwas found tobe required forexperimental
HEVinfectioninnonhumanprimatesand pigs[16,17].Foraglobal
overview of its role in HEV biology, we performed transcript
profiling of cultured Huh7 human hepatoma cells that were
transduced with recombinant adenoviruses expressing the ORF3
protein. This analysis revealed a large-scale modulation of gene
expression by the ORF3 protein. To understand the regulatory
mechanisms we analyzed the list of modulated genes and found
several down regulated genes to be known targets of hepatocyte
nuclear factor 4 (HNF4), a liver-enriched transcription factor.
Hepatocyte nuclear factor 4, an orphan member of the nuclear
receptor super family, regulates many genes that are preferentially
expressed in the liver [18]. In addition to a relatively high level of
expression in the liver, HNF4 mRNA and protein are also found in
thekidney,intestineandcolonand to alesserextentinpancreasand
stomach. The genes regulated by HNF4 play important roles in
nutrient transport and metabolism, blood maintenance, immune
function, liver differentiation and growth factors [18,19,20]. HNF4
binds DNA exclusively as a homodimer and is localized primarily in
thenucleus.Itcontainsa highlyconservedSer/Thr residue between
the two zinc fingers that is adjacent to a nuclear localization signal
(S78 in human HNF4). A recent report showed that phosphoryla-
tion of that site in HNF4 resulted in impaired nuclear localization
and DNA binding, which would decrease the transcriptional effects
of HNF4 [21]. HNF4 activity was also shown to be dependent upon
ERK and Akt kinases [22,23].
In this work we have carried out gene expression profiling of Huh7
liver cells expressing the HEV ORF3 protein and found several
downregulated genes to be controlled by the liver-enriched
transcription factor HNF4. We further showed that this was due to
E R K -a n dA k t - m e d i a t e dH N F 4p h o s p h o r y l a t i o n ,w h i c hr e d u c e d
nuclear translocation of HNF4 and attenuated its transcriptional
activity in ORF3-expressing cells. This study provides insights into the
modulation of liver-specific gene expression during HEV infection.
Materials and Methods
Plasmids and antibodies
The expression vectors and monoclonal antibodies for pORF3
have been described earlier [7,13]. The pShuttle-CMV-ORF3-
EGFP and pShuttle-CMV-EGFP constructs were made by
subcloning NheI-XbaI digested fragments from pORF3(114)-
EGFP and pEGFP-N1 into XbaI digested pShuttle-CMV. The
HEV replicon plasmid pSK-E2 was a kind gift from Suzanne
Emerson (NIH, USA), the pShuttle-CMV and pAdEasy-1
plasmids, E. coli BJ5183 and E. coli DH10B were from S.
Swaminathan (ICGEB, New Delhi, India) and the RFP-tagged
Rab5 construct was provided by Satyajit Mayor (National Centre
for Biological Sciences, India). The antibodies to phospho-ERK1,
ERK1, EGFP, HIF-1a, tubulin and phospho-tyrosine were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). The antibodies to phospho-Akt, Akt, HNF4, PARP and
STAT3 were purchased from Cell Signaling Technology (Beverly,
MA, USA). Antibodies to phospho-serine were purchased from
Sigma-Aldrich (St Louis, MO, USA). The HRP-conjugated
secondary antibodies were from Calbiochem (San Diego, CA,
USA) while the Alexa dye-conjugated secondary antibodies were
from Molecular Probes (Eugene, OR, USA).
Generation of recombinant adenoviral plasmids
The shuttle vector (1 mg) was linearized with PmeI and mixed
with 0.1 mg of supercoiled pAdEasy-1 in a total volume of 6 ml. To
this, 20 ml of electrocompetent E.coli BJ5183 cells were added, and
electroporation was performed in 2 mm cuvettes at 2500 V, 200
and 25 mF in a Bio-Rad Gene Pulser electroporator. The cells
were immediately placed in 1 ml of LB-media and grown at 37uC
for 45 min. The cells were then pelleted down, resuspended in
100 ml of LB medium and plated on LB agar plates containing
50 mg/ml of kanamycin. After 16–20 hr of growth at 37uC, the
smaller colonies (which usually represent the recombinants) were
picked and grown in 2 ml of LB-media containing 50 mg/ml of
kanamycin. Clones were first screened by analyzing their
supercoiled sizes on agarose gels and compared to pAdEasy-1
controls. Those that appeared to contain inserts were then
sequenced for final confirmation, and these were then electropo-
rated into E.coli DH10B cells for large-scale amplification.
Generation of recombinant adenoviruses
HEK-293 cells (ATCC) were plated in T25 flasks 24 hr prior to
transfection. Recombinant adenoviral DNA was linearized with
PacI and 4 mg was used together with 20 ml of Lipofectamine
(Invitrogen, Carlsbad, CA, USA) in 500 ml of OptiMEM for
transfection of each T25 flask. Transfected cells were monitored for
GFP expression, and 7–10 days post-transfection cells were
scrapped off and stored with culture media at 270uC. When
required, cells with media were lysed using 4–6 cycles of freezing in
liquid N2 and rapid thawing at 37uC. This lysate containing the
virus was centrifuged at 12000xg for 10 min to remove cellular
debris. The supernatant was stored at 270uC and used as the
primary adenovirus stock. For amplification of recombinant
adenoviruses, approximately 1.5610
6 HEK-293 cells were plated
in a T25 flask 24 hr prior to infection. Cells were washed once with
complete media and 1 ml of primary adenovirus stock was used to
infect these cells. After 2 hr at 37uC, the primary adenovirus stock
wasremoved,and 3 mlofgrowthmediumwasadded.Threetofour
days later, viruses were harvested as described above. This process
was repeated 4–6 times to get high titer virus.
Reverse transcription polymerase chain reaction
Total RNA was isolated from cells using the Trizol reagent
(Invitrogen, Carlsbad, CA, USA). Four mg RNA in a 25 ml
reaction mixture was used for cDNA synthesis with oligo dT
primers and Reverse Transcriptase (Promega, Madison, WI, USA)
according to the supplier’s protocol. Of this, 1 ml of the cDNA
mixture was used as a template for PCR amplification of target
genes. The PCR reactions were performed in a 50 ml volume
containing 1x reaction buffer, 200 mM dNTPs, 10 pmol of each
primer, and 1.25 units of Taq DNA polymerase (Real Biotech
Corporation, Taipei, Taiwan), for 30–35 cycles of 94uC for 30 sec,
55uC for 30 sec, 72uC for 30 sec, and a final extension at 72uC for
5 min. Real-time PCR was performed using 1 ml of the cDNA
mixture in a 20 ml volume containing 10 ml of 2X Power SYBRH
Green PCR Master Mix (Applied Biosystems, CA, USA) and
5 pmol of each primer for 40 cycles of 95uC for 30 sec, 55uC for
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a StepOnePlus
TM Real-Time PCR System (Applied Biosystems,
CA, USA). The threshold fluorescence level was automatically set
by the software, and the threshold cycle (CT) was determined for
each sample. Relative expression was calculated taking the control
as 100%. Primer sequences were generated using the Primer Bank
and were custom synthesized.
Immunoprecipitation and western blotting
Cells were lysed with a buffer containing 20 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton
X-100 and a protease inhibitor cocktail (Roche, Mannheim,
Germany). The clarified supernatant was quantified for protein
concentration by the Bradford assay (Bio-Rad Laboratories,
Hercules, USA). For immunoprecipitation, 1 mg of total proteins
in 500 ml of lysis buffer were incubated with 20 ml of Protein A-
agarose beads (GE Healthcare, Uppsala, Sweden) for 1 hr at 4uC.
The pre-cleared lysate was then incubated with 2 mg of the
antibody overnight at 4uC followed by 20 ml of Protein A-agarose
beads for 2 hr at 4uC. After five washes in lysis buffer, the beads
were boiled in Laemmli buffer, and the proteins separated by
SDS-PAGE. For western blotting, proteins separated by SDS-
PAGE were transferred to nitrocellulose membrane (Hybond
ECL, GE Healthcare), the membrane blocked with Tris-buffered
saline (TBS) containing 5% Blotto (Bio-Rad, Hercules, USA) for
1–2 hr at room temperature and washed with TBST (TBS
containing 0.1% Tween-20). The membrane was then incubated
overnight at 4uC with the primary antibody appropriately diluted
in TBST-5% BSA, washed thrice for 10 min each with TBST and
incubated with HRPO-linked secondary antibodies diluted in
TBST-5% Blotto for 1 hr at RT. After washing as above,
chemiluminescent detection of proteins was carried out using the
Phototope Detection System (Cell Signaling Technology, Beverly,
MA) according to the supplier’s protocol.
Replicon transfection and HEV infection
Plasmid pSK-E2 was linearized at a unique BglII site located
immediately downstream of the HEV poly(A) tract, and capped
transcripts were synthesized as previously described [24,25].
Transcription mixtures were cooled on ice and then mixed with a
liposome mixture consisting of 25 ml of DMRIE-C (1,2-dimyristylox-
ypropyl-3-dimethyl-hydroxy ethyl ammonium bromide and choles-
terol; Invitrogen, Carlsbad, CA) in 1 ml of Opti-MEM. This was
a d d e dt oaT 2 5f l a s kc o n t a i n i n gw a s h e dS 1 0 - 3c e l l sa ta b o u t4 0 %
confluence. The S10-3 cells are a subclone of the Huh7 cell line and
were a kind gift of Suzanne Emerson (NIH, USA). The flasks were
incubated at 34.5uC for 6 hr, an additional 1 ml of Opti-MEM was
added, and incubation was continued overnight. The cells were then
trypsinized, split into two T25 flasks, and incubated in Dulbecco’s
modified Eagle’s medium containing 10% FBS. On day 5 post-
transfection, cells were again trypsinized and plated for immuno-
staining, which was performed on day 8 post-transfection. For virus
infection, HEV was prepared as mentioned earlier [26]. For infection
0.2 ml of virion mix was added to the cells, and incubated at 37uCi n
a5 %C O 2 atmosphere for 2 hr, after which the liquid was replaced
with 1 ml of growth medium containing antibiotics. On day 3 post-
infection, cells were again trypsinized and plated for immunostaining,
which was performed on day 5 post-infection.
Microscopy
To study the localization of pORF3, recombinant adenovirus
infected Huh7 cells were transiently co-transfected with the
appropriate expression vectors. After 48 hr the cells were fixed
using 2% paraformaldehyde for 20 min and imaged using a
confocal microscope (Nikon A-1R). For the staining of endogenous
HNF4 and HEV replicon expressed pORF3, cells were fixed with
2% paraformaldehyde for 20 min, permeablized at room
temperature with 0.4% Triton X-100 for 15 min and stained
using the appropriate primary and secondary antibodies.
Microarray
Huh7 cell were infected with ORF3-EGFP and control EGFP
expressing recombinant adenoviruses. After 48 hr of infection, cells
wereharvestedandRNAwasisolatedfromboththetestandcontrol
samples using Trizol reagent (Invitrogen, USA). The extracted
RNAs were further purified using the RNeasy mini kit (Qiagen,-
USA) according to the manufacturer’s protocol. Of these, 10–12 mg
purified control and test RNAs were used as templates for cDNA
synthesis, using amino-allyl dNTPs, with the ChipShot Indirect
Labeling System (Promega, USA) according to the supplier’s
protocol. Purification of amino-allyl cDNA and post labeling with
Cyanine 3 or 5 (Amersham, Little Chalfont, UK) was carried out
with the same system. RNA extracted from control cells was labeled
with Cyanine 3 (Cy3) and that from test cells was labeled with
Cyanine 5 (Cy5). The samples were then lyophilized, resuspended
in hybridization buffer (Pronto
TM Universal Hybridization kit,
Corning) and incubated at 95uC for 5 min. The labeled cDNAs
from control and test samples were then mixed, centrifuged at high
speed for 5 min and hybridized on 35K_operon oligo_ver4.0
(Nicholas Piramal, Mumbai, India). The slides were given pre- and
post- hybridization treatment using the Pronto Universal Hybrid-
ization kit (Corning) according to the supplier’s instructions.
Hybridization was carried out in a Hybstation (Genomic Solutions)
hybridization chamber according to manufacturer’s instruction.
The hybridizationprofile used was42uC for 6 hr,35uC for6 hr and
30uC for 6 hr. Scanning and data analysis were performed as
described elsewhere [27]. Gene Ontology and transcription factor
analysis were done with FatiGO, a functional enrichment software.
The raw microarray data has been deposited in a MIAME
compliant database, as detailed on the MGED Society website
http://www.mged.org/Workgroups/MIAME/miame.html. The
GEO accession number for this data is GSE23412.
Results
Generation and characterization of ORF3 recombinant
adenovirus
Recombinant adenoviruses expressing the orf3-egfp or egfp were
constructed as described in Materials and Methods. Viral stock
normalization was done by RT-PCR for the adenovirus hexon gene.
The infectious titer of the adenovirus stock is usually determined by
plaque assay. But, that has several limitations including the length of
time required to perform the assay. The assay based on RT-PCR of
adenovirus mRNA is rapid, sensitive, and reproducible. Importantly,
there is a linear correlation between the titer determined by real-time
PCR and the infectious titer determined by a plaque assay [28].
Further, previous work from our lab suggested a cell survival role for
the HEV ORF3 protein[11]. A plaque assay based on cell death may
not give an accurate measurement of the infectious virus present. We
therefore used the RT-PCR based assay to normalize the
recombinant adenovirus titers.
Human hepatoma Huh7 cells were infected with different
dilutions of crude stocks of Ad-orf3-egfp and Ad-egfp viruses and
western blotting was used to test expression of the relevant proteins
(Fig. 1A). To ensure that pORF3 expressed from infection with
recombinant adenoviruses was functionally similar to that
expressed following plasmid transfection, we checked its effects
on HIF-1a and Akt. Analogous to earlier studies [12], higher levels
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Huh7 cells transduced with Ad-orf3-egfp compared to control Ad-
egfp (Fig. 1B). Our earlier studies using plasmid or replicon based
pORF3 expression showed this protein to localize to early and
recycling endosomes [7]. Huh7 cells were infected with the Ad-
orf3-egfp virus and 24 hr post-infection the cells were transfected
with a Rab5-RFP expression construct. As earlier, we found that
pORF3 expressed by the adenoviral recombinant also localized to
Rab5 positive compartments (Fig. 1C). These results support the
use of recombinant adenoviruses for subsequent studies.
Global modulation of gene expression by pORF3 in
hepatoma cells
The human genome contains ,25,000 predicted protein-
coding genes [29]. Viruses can cause large-scale modulation of
host genes to optimize their own replication and pathogenesis;
such changes in host gene expression are analyzed using high
throughput platforms such as microarrays [30]. We infected Huh7
cells with the Ad-orf3-egfp and Ad-egfp recombinant adenoviruses
and purified the cellular RNA. The labeled cDNA synthesis,
hybridization to a 35K_operon oligo_ver4.0 Human Array
(Nicholas Piramal, India), scanning and data analysis were
performed as described in Materials and Methods. Fold-change
analysis showed a considerable difference in the gene expression
profile of the ORF3-expressing cells compared to control cells. To
make the data more robust we repeated this experiment three
times and considered only those genes that showed similar profiles
in all three experiments (Fig. S1). We found 221 genes to be down
regulated and 115 genes to be upregulated in ORF3 expressing
cells (Tables S1 and S2). One of the goals of microarray data
analysis is to cluster genes with similar functional profiles to make
meaningful biological inferences. FatiGO is a web tool that carries
out data mining using Gene Ontology (GO) for DNA microarray
data. The modulated genes were analyzed with this software to
understand the biological pathways modulated by pORF3; these
were divided into several clusters on the basis of GO terms (Fig. 2).
This clustering indicated that pORF3 modulated several biological
processes, especially metabolic pathways in the host cell.
The ORF3 protein down regulates hepatocyte nuclear
factor 4 dependent genes by interfering with its nuclear
translocation
Gene expression is modulated by transcription factors that
occupy specific binding sites within the promoter/enhancer
Figure 1. Functional characterization of the ORF3 protein expressed from adenoviral recombinants. (A) Huh7 cells were infected with
different dilutions of the Ad-orf3-egfp and Ad-egfp recombinant adenoviruses. After 36 hr, the cells were lysed and the lysates western blotted with
anti-GFP antibodies. Lane +C contains positive control lysate of Huh7 cells transfected to express ORF3-EGFP or EGFP. No signal was observed in
uninfected cells (not shown). (B) Huh7 cells were infected with the Ad-orf3-egfp or Ad-egfp recombinant adenoviruses. After 48 hr, the cells were
harvested and cell lysates were western blotted with anti-HIF1a, anti-pAkt or anti-Akt antibodies. Western blotting with anti-ERK and anti-EGFP
served as loading and expression controls, respectively. (C) Huh-7 cells were infected with ORF3-EGFP expressing recombinant adenovirus. After
24 hr, the cells were transfected with a Rab5-RFP expression construct, and 36 hr later, the cells were imaged by confocal microscopy. Monochrome
and pseudocolored details of the boxed regions are shown and coded according to the color assigned for each entity.
doi:10.1371/journal.pone.0022412.g001
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22412Figure 2. The ORF3 protein modulates several host processes. The modulated genes were analyzed with the FatiGO software and were
divided into several clusters on the basis of GO terms. Only those GO classes with $3% genes are shown.
doi:10.1371/journal.pone.0022412.g002
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was responsible for pORF3-mediated modulation of host genes,
we analyzed the modulated gene lists using FatiGO [31]. Our
analysis found 79 (35.7%) of the 221 down regulated genes to be
known targets of hepatocyte nuclear factor 4 (HNF4), a liver-
enriched transcription factor. To validate the effects of pORF3 on
HNF4-modulated genes, we carried out RT-PCR and real-time
RT-PCR analysis for eight such randomly chosen genes using
gene-specific primers (Table S3). As expected, both analyses
showed decreased expression of ATF1, CD72, MAOA, TCF1,
RASA2, ATP5J, SP110 and POLD4 (Fig. 3).
The HNF4 transcription factor regulates many liver-specific
genes [18]. To check the cellular levels of HNF4, we infected
Huh7 cells with the recombinant adenoviruses, prepared total,
cytoplasmic and nuclear lysates, and carried out Western blotting
with anti-HNF4 antibodies. While no difference was observed in
the total HNF4 protein levels, higher cytoplasmic and lower
nuclear levels of HNF4 were found in cells expressing pORF3
(Fig. 4A), suggesting that it might interfere with the nuclear
localization of HNF4. The subcellular localization of HNF4 was
also checked by confocal microscopy. While in control cells, HNF4
was quantitatively localized to the nucleus (Fig. 4Ba), in ORF3-
expressing cells it was predominantly found in the cytoplasm
(Fig. 4Bb,c,d). This subcellular localization of HNF4 was identical
in cells expressing either the ORF3-EGFP fusion protein from a
plasmid vector (Fig. 4Bb) or the native ORF3 protein from a
transfected HEV replicon (Fig. 4Bc). Similar HNF4 and pORF3
localization was also observed in cells infected with HEV
(Fig. 4Bd). These results suggest that pORF3 interferes with the
nuclear localization of HNF4, which in turn is responsible for the
reduced expression of HNF4 responsive genes.
The pORF3-mediated phosphorylation of HNF4 is
responsible for its reduced nuclear translocation and
transcriptional activity
The ORF3 protein is likely to modulate the subcellular
localization of HNF4 in two possible ways. It could interact with
HNF4 and trap it in the cytoplasm or endosomal compartments
where pORF3 is mainly present. Alternatively, pORF3 could
interfere with the regulatory mechanism responsible for the
nuclear localization of HNF4. A recent report suggested that
phosphorylation of a highly conserved serine (Ser78) in HNF4
resulted in its impaired nuclear localization [21]. Further, HNF4
activity was shown to depend upon ERK and Akt kinases [22,23].
Our previous studies have shown that ERK and Akt are activated
in ORF3-expressing cells as well [10,12]. To test for these
alternative pathways, Huh7 cells were transfected with plasmids
expressing ORF3-EGFP or EGFP (control). The cell lysates were
Figure 3. The ORF3 protein modulates HNF4 responsive genes. The list shows all HNF4 responsive genes that were found to be down
regulated in Ad-orf3-egfp infected Huh7 cells compared to Ad-egfp infected cells. The genes shown in bold were validated by RT-PCR and real-time
RT-PCR. For that, Huh7 cells were infected with the recombinant adenoviruses, and 48 hr post-infection, RNA was prepared and RT-PCR and real-time
RT-PCR were carried out using primers shown in Table S3. Histone H4 served as a loading control for RNA. For real time RT-PCR relative expression
was calculated taking the control as 100%.
doi:10.1371/journal.pone.0022412.g003
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with either anti-phosphoSerine (for phospho-HNF4) or anti-EGFP
(for pORF3) antibodies. We did not find co-immunoprecipitation
of pORF3 and HNF4 (data not shown) but found significant
increase in phosphorylated HNF4 levels in ORF3-expressing cells
(Fig. 5A). It was not possible to demonstrate these effects of the
ORF3 protein on HNF4 phosphorylation with the full-length
replicon due to its poor replication efficiency and a delay of 3-4
weeks in producing measurable virions in culture. We have earlier
shown the hydrophobic domain 1 of pORF3 to be responsible for
ERK activation. Here we found reduced HNF4 phosphorylation
in cells expressing the domain 1-deleted (DD1) ORF3 protein
compared to the wild type protein (Fig. 5A). Blocking of Akt
activation with its pharmacological inhibitor LY294002 also
resulted in attenuation of pORF3-mediated HNF4 phosphoryla-
tion (Fig. 5B). The use of a dominant negative mutant of the
catalytic subunit of phosphoinositide 3-kinase (p110DN) did not
show any measurable effects on pORF3-mediated HNF4
phosphorylation (not shown). To confirm that the pORF3-
mediated effect on HNF4 nuclear localization was due to its
phosphorylation, we blocked both the kinases by treating DD1-
ORF3 expressing cells with LY294002, and checked the nuclear
levels and transcription factor activity of HNF4. In these cells, the
nuclear levels of HNF4 were comparable to control cells (Fig. 5C),
and the transcriptional repression of HNF4-responsive genes was
also relieved (Fig. 5D). Together these results confirm that HEV
pORF3 increases HNF4 phosphorylation through the activation of
ERK and Akt pathways. This is responsible for reduced nuclear
localization and transcription factor activity of HNF4.
Discussion
The host-pathogen interface represents the ultimate battle-
ground for survival. Considerable progress has been made in
understanding the roles that viral and cellular proteins play in
determining the host susceptibility to infection and disease. Like
most viruses, HEV also modulates the host cell machinery for its
replication and pathogenesis. The HEV genome encodes the
ORF1, ORF2 and ORF3 proteins, of which the ORF3 protein
appears to possess host cell regulatory properties [32,33]. Based on
Figure 4. The ORF3 protein interferes with the nuclear localization of HNF4. (A) Huh7 cell were infected with the control and ORF3-
expressing recombinant adenoviruses. After 48 hr, total, cytoplasmic and nuclear lysates were prepared and western blotted with anti-HNF4. ERK and
STAT3 served as loading controls for cytoplasmic and nuclear fractions, respectively. The cytoplasmic and nuclear lysates were also checked for
tubulin and PARP to confirm their purity. (B) Huh7 cells were transfected with (a) pEGFP-N1 expression vector, (b) the pORF3-EGFP expression vector
or (c) in vitro synthesized capped HEV replicon RNA. In panel (d) cells were infected with HEV prepared by replicon transfection as described. The cells
were fixed and stained with anti-HNF4 and Alexa568-conjugated secondary antibodies, and DAPI (for nuclei). In (c) and (d) the cells were also stained
with anti-ORF3 and Alexa488-conjugated secondary antibodies. The fixed cells were then imaged on a Nikon AR-1 confocal microscope. The EGFP or
ORF3 protein, DAPI and HNF4 signals were pseudocolored green, blue and red, respectively. The merged pictures of single confocal planes are
shown.
doi:10.1371/journal.pone.0022412.g004
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protein in HEV pathogenesis. The first is promotion of cell
survival through ERK activation [10], attenuation of the intrinsic
death pathway [11] and regulation of energy homeostasis [12].
The second is to down regulate host innate immune responses
through reduced expression of acute phase proteins [7] and
increased secretion of a1-microglobulin, an immunosuppressive
protein [14]. Finally, it is shown to have a role in virion
morphogenesis and viral release from infected cells [15]. Thus,
pORF3 appears to be a pleiotropic regulatory protein that helps in
the establishment and propagation of HEV infection by
modulating multiple pathways. We therefore planned to get a
global overview of the effects of ORF3 expression on liver cells.
Due to the lack of traditional in vitro viral infection systems or
efficient replicon systems, which can be used to study the effects of
HEV proteins on cellular processes, our previous strategy was
mainly based on subgenomic expression of pORF3.
In the last decade, recombinant adenovirus vectors have been
used for a variety of purposes, including gene transfer in vitro and in
vivo. The ability of recombinant adenoviruses to transduce a broad
variety of cell types with high efficiency, regardless of the
proliferative state of the target cells, as well as their relative ease
of manipulation and preparation, makes them very powerful tools
in mammalian gene expression studies. We therefore constructed
recombinant adenoviruses expressing the ORF3 protein to check
its importance for HEV infection, genome replication and
Figure 5. The ORF3 protein modulates HNF4 phosphorylation. (A) Huh7 cells were transfected to express EGFP (control) or the ORF3-EGFP or
DD1-ORF3-EGFP fusion protein, and cells were harvested 48 hr post-infection. Cell lysates containing equal amounts of total protein were
immunoprecipitated with anti-HNF4 and then western blotted with anti-pSerine antibody. Normalized lysates were western blotted with anti-HNF4
and anti-GFP antibodies for loading and expression controls, respectively. Normalized lysates were also western blotted with anti-pERK and anti-ERK
to show the effect of pORF3 on ERK activation. (B) Huh7 cells were infected with ORF3 expressing (+) and control (2) recombinant adenoviruses. At
36 hr post infection, the cells were treated with either 50 mM LY294002 or an equal volume of DMSO for 12 hr. Cells were harvested 48 hr post-
infection and lysates containing equal amounts of total protein were immunoprecipitated with anti-HNF4 and followed by western blotting with anti-
pSerine antibody. Normalized lysates were western blotted with anti-HNF4 and anti-GFP antibodies for loading and expression controls, respectively.
Normalized lysates were also western blotted with anti-pAkt and anti-Akt to show the effect of pORF3 on Akt activation. (C) Huh7 cells were
transfected to express EGFP (control) or the ORF3-EGFP or DD1-ORF3-EGFP fusion protein. At 36 hr post-transfection, the cells transfected with DD1-
ORF3-EGFP expressing plasmid were treated with 50 mM LY294002 and others were treated with an equal volume of DMSO for 12 hr. Nuclear lysates
were prepared and western blotted with anti-HNF4. STAT3 served as a loading control. (D) Huh7 cells were transfected and treated as described in
(C). RT-PCR analysis was performed as mentioned earlier. Histone H4 served as a loading control for RNA.
doi:10.1371/journal.pone.0022412.g005
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earlier studies showed that pORF3 localizes to early and recycling
endosomal compartments [7]. The adenovirus-expressed pORF3
faithfully localized to Rab5 positive compartments, as is the case
with pORF3 expressed from HEV replicons or subgenomic
expression vectors. We also checked its functional effect on some of
the host proteins and found similar effects following expression
using the adenovirus background. These finding support the use of
recombinant adenovirus for gene expression analysis. To enhance
our understanding of the role of pORF3 in HEV biology,
hepatoma cells were infected with ORF3 or control recombinant
adenoviruses and microarray-based gene expression analysis was
carried out. Of the 25,500 genes that were analyzed, 115 genes
were upregulated and 221 genes down regulated consistently in
ORF3-expressing cells. All these genes were functionally grouped
using the FatiGO software and were found to be grouped in
different gene ontology (GO) functional groups [31]. The ORF3
protein was found to affect several pathways, especially the
metabolic and signaling pathways. Transcription factor analyses
showed a large number of genes driven by HNF4 to be down
regulated in ORF3-expressing cells.
The HNF4 transcription factor is expressed mainly in the liver
and plays important roles in nutrient transport and metabolism,
blood maintenance, immune function, liver differentiation and
expression of growth factors [18,19,20]. The HNF4 protein is
expressed early in embryonic life, long before liver development
and mice deleted for this gene die in utero between days 9.5-10.5,
and exhibit impaired gastrulation [20]. In the adult liver, HNF4 is
required for its proper function. Other hepatotropic viruses like
HBV and HCV also modulate HNF4 for their efficient replication
and pathogenesis [34,35]. An earlier study from our group also
found lower plasma levels of albumin and transthyretin in HEV
infected patients [36]; the genes for these are major targets of
HNF4. On transcriptional analysis, several of the down regulated
genes were found to be regulated by HNF4, and this was also
observed in nuclear levels of the HNF4 protein. Our microscopy
data clearly proved that in a replicon expression model as well as
in a virus infection system, pORF3 modulated the nuclear
localization of HNF4. A recent report suggested that phosphor-
ylation of a highly conserved serine (Ser78) in HNF4 resulted in its
impaired nuclear localization [21], and HNF4 activity was
dependent upon ERK and Akt kinases [22,23]. Our previous
studies have shown that ERK and Akt are also activated in ORF3-
expressing cells [10,12]. To test for these alternative pathways, we
used the hydrophobic domain 1 deleted pORF3 which is unable to
activate ERK and the pharmacological inhibitor LY294002 that
blocks Akt activation, and found that this inhibition significantly
reduces pORF3-mediated phosphorylation of HNF4. However,
blocking of either pathway alone was not sufficient to completely
revert this effect. Our results indicate that pORF3 regulates several
hepatotropic proteins by inducing the phosphorylation of HNF4,
which would in turn reduce its translocation to the nucleus and
attenuate its transcription factor activity.
We have demonstrated large-scale modulation of HNF4-
mediated gene expression as a consequence of ORF3 expression
in Huh7 cells. One shortcoming of our work is its inability to
directly demonstrate whether any of these changes in Huh7 cells
actually affected HEV replication. An orf3-deleted HEV replicon
replicates just as well as the wild type replicon when transfected
into Huh7 cells [25]. However, the ORF3 protein is required for
successful infection, virus replication and liver injury in macaques
[16]. Thus, we are not likely to see the effects of the ORF3 protein
on HEV replication in this Huh7 culture model. The macaque
model appears to be the only one in which this could be done, and
that is beyond the scope of this study.
Collectively our data provide a novel example of a viral protein
that blocks the expression of several liver-specific genes by
modulating the nuclear localization of HNF4. By regulating
HNF4 localization and thereby its transcription factor activity,
HEV is likely to modulate the expression of several hepatocyte
genes. This could contribute positively to viral replication and
pathogenesis.
Supporting Information
Figure S1 Heat map of cellular genes modulated in
ORF3 expressing cells. A heat map of genes modulated in the
ORF3 expressing cells is shown for all three technical replicates,
which was generated using software TM4 MultiExperiment
Viewer. Gene list is in the same order as given in Table S1 (for
down regulated genes) and Table S2 (for upregulated genes). The
log2 transformed fold-change values were loaded and genes were
sorted in load order to prepare the heat map. Color bar represents
log2 transformed fold change values from 23.15 to + 3.15.
(TIF)
Table S1 Cellular genes down regulated in ORF3-
expressing cells.
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Table S2 Cellular genes upregulated in ORF3-
expressing cells.
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